The Peptide Gold Rush Is Coming

An advisory committee to the Food and Drug Administration voted to recommend that compounding pharmacies be allowed to make the peptide BPC-157. This recommendation comes despite limited human safety data and the peptide not passing the normal FDA drug-approval process.